Neurology
Found 608 results
2017
Robbins MS.  2017.  Comment: Headache medicine as an emerging subspecialty-Irony and reality.. Neurology. 88(13):e124.
Parikh NS, Schweitzer AD, Young RJ, Giambrone AE, Lyo J, Karimi S, Knobel A, Gupta A, Navi BB.  2017.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.. J Neurol Sci. 380:11-15.
Robbins MS, Haut SR, Lipton RB, Milstein MJ, Ocava LC, Ballaban-Gil K, Moshé SL, Mehler MF.  2017.  A dedicated scholarly research program in an adult and pediatric neurology residency program.. Neurology. 88(14):1366-1370.
Kaunzner UW, Al-Kawaz M, Gauthier SA.  2017.  Defining Disease Activity and Response to Therapy in MS.. Curr Treat Options Neurol. 19(5):20.
Seifan A, Ganzer CA, Vermeylen F, Parry S, Zhu J, Lyons A, Isaacson R, Kim S.  2017.  Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort-a behavioral theory approach.. J Public Health (Oxf). 39(4):863-873.
Al-Kawaz M, Monohan E, Morris E, Perumal JS, Nealon N, Vartanian T, Gauthier SA.  2017.  Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans.. J Neuroimaging. 27(3):333-338.
Parikh NS, Merkler AE, Schneider Y, Navi BB, Kamel H.  2017.  Discharge Disposition After Stroke in Patients With Liver Disease.. Stroke. 48(2):476-478.
Pereira AC, Mao X, Jiang CS, Kang G, Milrad S, McEwen BS, Krieger AC, Shungu DC.  2017.  Dorsolateral prefrontal cortex GABA deficit in older adults with sleep-disordered breathing.. Proc Natl Acad Sci U S A. 114(38):10250-10255.
Barone DA, Ebben MR, DeGrazia M, Mortara D, Krieger AC.  2017.  Heart rate variability in restless legs syndrome and periodic limb movements of Sleep.. Sleep Sci. 10(2):80-86.
Schweitzer AD, Parikh NS, Askin G, Nemade A, Lyo J, Karimi S, Knobel A, Navi BB, Young RJ, Gupta A.  2017.  Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.. Neuroradiology. 59(4):379-386.
Eskreis-Winkler S, Zhou D, Liu T, Gupta A, Gauthier SA, Wang Y, Spincemaille P.  2017.  On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.. Magn Reson Imaging. 35:154-159.
Broner SW, Bobker S, Klebanoff L.  2017.  Migraine in Women.. Semin Neurol. 37(6):601-610.
Dayan M, Rúa SMHurtado, Monohan E, Fujimoto K, Pandya S, LoCastro EM, Vartanian T, Nguyen TD, Raj A, Gauthier SA.  2017.  MRI Analysis of White Matter Myelin Water Content in Multiple Sclerosis: A Novel Approach Applied to Finding Correlates of Cortical Thinning.. Front Neurosci. 11:284.
Kaunzner UW, Gauthier SA.  2017.  MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.. Ther Adv Neurol Disord. 10(6):247-261.
Patke A, Murphy PJ, Onat OEmre, Krieger AC, Özçelik T, Campbell SS, Young MW.  2017.  Mutation of the Human Circadian Clock Gene CRY1 in Familial Delayed Sleep Phase Disorder.. Cell. 169(2):203-215.e13.
Gusdon AM, Gialdini G, Kone G, Baradaran H, Merkler AE, Mangat HS, Navi BB, Iadecola C, Gupta A, Kamel H et al..  2017.  Neutrophil-Lymphocyte Ratio and Perihematomal Edema Growth in Intracerebral Hemorrhage.. Stroke. 48(9):2589-2592.
Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G.  2017.  No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.. Mult Scler. 23(13):1736-1747.
Ebben MR.  2017.  Nonpharmacologic Management of Excessive Daytime Sleepiness.. Sleep Med Clin. 12(3):479-487.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung H-P, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K et al..  2017.  Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.. N Engl J Med. 376(3):221-234.
Rumah KR, Vartanian TK, Fischetti VA.  2017.  Oral Multiple Sclerosis Drugs Inhibit the Growth of Epsilon Toxin Producing Gut Bacterium, .. Front Cell Infect Microbiol. 7:11.
Murthy SB, Merkler AE, Omran SSalehi, Gialdini G, Gusdon A, Hartley B, Roh D, Mangat HS, Iadecola C, Navi BB et al..  2017.  Outcomes after intracerebral hemorrhage from arteriovenous malformations.. Neurology. 88(20):1882-1888.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.. PLoS One. 12(10):e0185926.
Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron J-L, Huang J, Camarata P, Lara LRivera et al..  2017.  Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.. Neurology. 89(4):355-362.
Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.  2017.  Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.. AJR Am J Roentgenol. 209(4):889-894.
Nguyen TD, Spincemaille P, Gauthier SA, Wang Y.  2017.  Rapid whole brain myelin water content mapping without an external water standard at 1.5T.. Magn Reson Imaging. 39:82-88.